- Home
- SAGE vs ISD Comparison
SAGE vs ISD Comparison
Compare SAGE & ISD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAGE
- ISD
- Stock Information
- Founded
- SAGE 2010
- ISD 2012
- Country
- SAGE United States
- ISD United States
- Employees
- SAGE N/A
- ISD N/A
- Industry
- SAGE Biotechnology: Pharmaceutical Preparations
- ISD Trusts Except Educational Religious and Charitable
- Sector
- SAGE Health Care
- ISD Finance
- Exchange
- SAGE Nasdaq
- ISD Nasdaq
- Market Cap
- SAGE 571.7M
- ISD 459.0M
- IPO Year
- SAGE 2014
- ISD N/A
- Fundamental
- Price
- SAGE $9.08
- ISD $14.28
- Analyst Decision
- SAGE Hold
- ISD
- Analyst Count
- SAGE 18
- ISD 0
- Target Price
- SAGE $10.06
- ISD N/A
- AVG Volume (30 Days)
- SAGE 2.8M
- ISD 127.1K
- Earning Date
- SAGE 07-30-2025
- ISD 01-01-0001
- Dividend Yield
- SAGE N/A
- ISD 9.69%
- EPS Growth
- SAGE N/A
- ISD N/A
- EPS
- SAGE N/A
- ISD N/A
- Revenue
- SAGE $47,404,000.00
- ISD N/A
- Revenue This Year
- SAGE $102.21
- ISD N/A
- Revenue Next Year
- SAGE $43.01
- ISD N/A
- P/E Ratio
- SAGE N/A
- ISD N/A
- Revenue Growth
- SAGE N/A
- ISD N/A
- 52 Week Low
- SAGE $4.62
- ISD $10.98
- 52 Week High
- SAGE $13.47
- ISD $13.17
- Technical
- Relative Strength Index (RSI)
- SAGE 71.54
- ISD 70.37
- Support Level
- SAGE $9.04
- ISD $13.97
- Resistance Level
- SAGE $9.30
- ISD $13.95
- Average True Range (ATR)
- SAGE 0.15
- ISD 0.13
- MACD
- SAGE 0.05
- ISD 0.05
- Stochastic Oscillator
- SAGE 91.35
- ISD 98.51
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.
About ISD PGIM High Yield Bond Fund Inc.
PGIM High Yield Fund Inc is a diversified, closed-end management investment company, active in the financial services domain. The Fund's investment objective is to provide a high level of current income. It invests at least 80% of its investable assets in a diversified portfolio of high-yield fixed-income instruments that are rated below investment grade with varying maturities and other investments.